IDiyas

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Thomas O Daniel

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 6.1

ph-index = 11

Forward Citations = 260(Granted Patents)


Company Filing History:

goldMedal13 out of 113 
 
Ambrx, Inc.
 patents
silverMedal2 out of 549 
 
Celgene Corporation
 patents

Years Active: 2009-2018

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 10047151 - Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor (2018-08-14),
2. 9365640 - Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor (2016-06-14),
3. 9260472 - Modified human four helical bundle polypeptides and their uses (2016-02-16),
4. 9175083 - Antigen-binding polypeptides and their uses (2015-11-03),
5. 8907064 - Modified human four helical bundle polypeptides and their uses (2014-12-09),
6. 8906676 - Modified human four helical bundle polypeptides and their uses (2014-12-09),
7. 8778880 - Human growth hormone modified at position 35 (2014-07-15),
8. 8232371 - Modified human interferon polypeptides and their uses (2012-07-31),
9. 8143216 - Modified human growth hormone (2012-03-27),
10. 8119603 - Modified human interferon polypeptides and their uses (2012-02-21),
11. 8097702 - Modified human interferon polypeptides with at least one non-naturally encoded amino acid and their uses (2012-01-17),
12. 8093356 - Pegylated human interferon polypeptides (2012-01-10),
13. 7939496 - Modified human growth horomone polypeptides and their uses (2011-05-10),
14. 7638299 - Biosynthetic polypeptides utilizing non-naturally encoded amino acids (2009-12-29),
15. 7632924 - Antigen-binding polypeptides and their uses (2009-12-15),

Title: Innovations of Thomas O Daniel in Cancer Treatment

Introduction

Thomas O Daniel is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of medical research, particularly in the treatment of cancer and inflammatory diseases. With a total of 15 patents to his name, his work has had a profound impact on patient care and drug treatment methodologies.

Latest Patents

Among his latest patents, Thomas O Daniel has developed methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor. This innovative approach utilizes the protein cereblon to predict clinical sensitivity to cancer and inflammatory diseases, as well as patient responses to drug treatments. His research aims to enhance the effectiveness of therapies and improve patient outcomes.

Career Highlights

Throughout his career, Thomas O Daniel has worked with notable companies such as Ambrx, Inc. and Celgene Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Ho Sung Cho and Anna-Maria A Hays. Their collaborative efforts have further advanced the research and development of innovative treatments in the medical field.

Conclusion

Thomas O Daniel's contributions to cancer treatment and inflammatory disease research exemplify the importance of innovation in medicine. His work continues to pave the way for new therapeutic strategies that can significantly improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…